Evaluation of Patients With Gastrointestinal Disease

Launched by NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES (NIDDK) · Sep 10, 2021

Keywords

ClinConnect Summary

This clinical trial is studying gastrointestinal diseases, which affect the lower part of the digestive system. Researchers at the National Institutes of Health (NIH) want to collect data and biological samples from adults who have known or suspected gastrointestinal disorders. This information will help them improve how these diseases are assessed and treated in the future.

To participate, you need to be at least 18 years old and have a gastrointestinal issue that requires screening or treatment, based on current medical guidelines. If you join the study, you will have a physical exam and your medical history will be reviewed. You’ll receive the same care you would at any doctor’s office, but in addition, you may be asked to provide samples of blood, urine, or stool. If you have certain procedures like an endoscopy or colonoscopy, you might also be asked to share any leftover samples. All collected data will be securely stored and coded to protect your privacy. The study is currently recruiting participants, so if you think you might be eligible, consider reaching out for more information.

Gender

ALL

Eligibility criteria

• * INCLUSION CRITERIA:
• In order to be eligible to participate in this study, an individual must meet all of the following criteria:
• • 1. Male or female, aged \>= 18 years of age
• • 2. Known or suspected gastrointestinal disorders or requiring clinical screening, management and/or treatment and follow-up per current American Gastroenterological Association (AGA), American Society for Gastrointestinal Endoscopy (ASGE) or the American Association for the Study of Liver Disease (AASLD).
• EXCLUSION CRITERIA:
• An individual who meets any of the following criteria will be excluded from participation in this study:
• • 1. Significant medical illnesses that the investigators feel may interfere with potential evaluations.
• • 2. Absence of a referring community physician who would be able to manage care outside of the NIH.
• • 3. Any medical, psychiatric, or social conditions which, in the opinion of the investigators, would make participation in this protocol not in the best interest of the patient.
• • 4. Inability to provide informed consent.